Mycobacterium tuberculosis specific CD8(+) T cells rapidly decline with antituberculosis treatment.
Nyendak MR, Park B, Null MD, Baseke J, Swarbrick G, Mayanja-Kizza H, Nsereko M, Johnson DF, Gitta P, Okwera A, Goldberg S, Bozeman L, Johnson JL, Boom WH, Lewinsohn DA, Lewinsohn DM; Tuberculosis Research Unit and the Tuberculosis Trials Consortium.
Nyendak MR, et al. Among authors: baseke j.
PLoS One. 2013 Dec 4;8(12):e81564. doi: 10.1371/journal.pone.0081564. eCollection 2013.
PLoS One. 2013.
PMID: 24324704
Free PMC article.
Clinical Trial.